455 related articles for article (PubMed ID: 20639483)
1. CD4+ CD25+ regulatory T cells prevent type 1 diabetes preceded by dendritic cell-dominant invasive insulitis by affecting chemotaxis and local invasiveness of dendritic cells.
Lee MH; Lee WH; Todorov I; Liu CP
J Immunol; 2010 Aug; 185(4):2493-501. PubMed ID: 20639483
[TBL] [Abstract][Full Text] [Related]
2. Image-guided analyses reveal that non-CD4 splenocytes contribute to CD4+ T cell-mediated inflammation leading to islet destruction by altering their local function and not systemic trafficking patterns.
Lee MH; Lee WH; Van Y; Contag CH; Liu CP
Mol Imaging; 2007; 6(6):369-83. PubMed ID: 18053408
[TBL] [Abstract][Full Text] [Related]
3. Evidence for an enhanced adhesion of DC to fibronectin and a role of CCL19 and CCL21 in the accumulation of DC around the pre-diabetic islets in NOD mice.
Bouma G; Coppens JM; Mourits S; Nikolic T; Sozzani S; Drexhage HA; Versnel MA
Eur J Immunol; 2005 Aug; 35(8):2386-96. PubMed ID: 16047341
[TBL] [Abstract][Full Text] [Related]
4. Characteristics of rat CD4(+)CD25(+) T cells and their ability to prevent not only diabetes but also insulitis in an adoptive transfer model in BB rats.
Holm TL; Lundsgaard D; Markholst H
Scand J Immunol; 2006 Jul; 64(1):17-29. PubMed ID: 16784487
[TBL] [Abstract][Full Text] [Related]
5. All-trans retinoic acid inhibits type 1 diabetes by T regulatory (Treg)-dependent suppression of interferon-gamma-producing T-cells without affecting Th17 cells.
Van YH; Lee WH; Ortiz S; Lee MH; Qin HJ; Liu CP
Diabetes; 2009 Jan; 58(1):146-55. PubMed ID: 18984738
[TBL] [Abstract][Full Text] [Related]
6. Control of type 1 autoimmune diabetes by naturally occurring CD4+CD25+ regulatory T lymphocytes in neonatal NOD mice.
Piccirillo CA; Tritt M; Sgouroudis E; Albanese A; Pyzik M; Hay V
Ann N Y Acad Sci; 2005 Jun; 1051():72-87. PubMed ID: 16126946
[TBL] [Abstract][Full Text] [Related]
7. Dendritic cell-expanded, islet-specific CD4+ CD25+ CD62L+ regulatory T cells restore normoglycemia in diabetic NOD mice.
Tarbell KV; Petit L; Zuo X; Toy P; Luo X; Mqadmi A; Yang H; Suthanthiran M; Mojsov S; Steinman RM
J Exp Med; 2007 Jan; 204(1):191-201. PubMed ID: 17210729
[TBL] [Abstract][Full Text] [Related]
8. Study on pancreatic lymphatics in nonobese diabetic mouse with prevention of insulitis and diabetes by adjuvant immunotherapy.
Qu P; Ji RC; Shimoda H; Miura M; Kato S
Anat Rec A Discov Mol Cell Evol Biol; 2004 Dec; 281(2):1326-36. PubMed ID: 15386276
[TBL] [Abstract][Full Text] [Related]
9. CD4+CD25+ regulatory T cells control the progression from periinsulitis to destructive insulitis in murine autoimmune diabetes.
Ott PA; Anderson MR; Tary-Lehmann M; Lehmann PV
Cell Immunol; 2005 May; 235(1):1-11. PubMed ID: 16122720
[TBL] [Abstract][Full Text] [Related]
10. Both central and peripheral tolerance mechanisms play roles in diabetes prevention in NOD-E transgenic mice.
Mellanby RJ; Phillips JM; Parish NM; Cooke A
Autoimmunity; 2008 Aug; 41(5):383-94. PubMed ID: 18568644
[TBL] [Abstract][Full Text] [Related]
11. Increased diabetes development and decreased function of CD4+CD25+ Treg in the absence of a functional DAP12 adaptor protein.
Hall HT; Sjölin H; Brauner H; Tomasello E; Dalod M; Vivier E; Höglund P
Eur J Immunol; 2008 Nov; 38(11):3191-9. PubMed ID: 18925576
[TBL] [Abstract][Full Text] [Related]
12. Flow cytometric enumeration of mononuclear cell populations infiltrating the islets of Langerhans in prediabetic NOD mice: development of a model of autoimmune insulitis for type I diabetes.
Jarpe AJ; Hickman MR; Anderson JT; Winter WE; Peck AB
Reg Immunol; 1990-1991; 3(6):305-17. PubMed ID: 2132756
[TBL] [Abstract][Full Text] [Related]
13. IL-10-conditioned dendritic cells prevent autoimmune diabetes in NOD and humanized HLA-DQ8/RIP-B7.1 mice.
Tai N; Yasuda H; Xiang Y; Zhang L; Rodriguez-Pinto D; Yokono K; Sherwin R; Wong FS; Nagata M; Wen L
Clin Immunol; 2011 Jun; 139(3):336-49. PubMed ID: 21458378
[TBL] [Abstract][Full Text] [Related]
14. Immune tolerance induced by adoptive transfer of dendritic cells in an insulin-dependent diabetes mellitus murine model.
Zhang CL; Zou XL; Peng JB; Xiang M
Acta Pharmacol Sin; 2007 Jan; 28(1):98-104. PubMed ID: 17184588
[TBL] [Abstract][Full Text] [Related]
15. Upregulating CD4+CD25+FOXP3+ regulatory T cells in pancreatic lymph nodes in diabetic NOD mice by adjuvant immunotherapy.
Tian B; Hao J; Zhang Y; Tian L; Yi H; O'Brien TD; Sutherland DE; Hering BJ; Guo Z
Transplantation; 2009 Jan; 87(2):198-206. PubMed ID: 19155973
[TBL] [Abstract][Full Text] [Related]
16. CD4+CD25+Foxp3+ regulatory T cells are dispensable for controlling CD8+ T cell-mediated lung inflammation.
Tosiek MJ; Gruber AD; Bader SR; Mauel S; Hoymann HG; Prettin S; Tschernig T; Buer J; Gereke M; Bruder D
J Immunol; 2011 Jun; 186(11):6106-18. PubMed ID: 21518973
[TBL] [Abstract][Full Text] [Related]
17. Plasmacytoid dendritic cells license regulatory T cells, upon iNKT-cell stimulation, to prevent autoimmune diabetes.
Beaudoin L; Diana J; Ghazarian L; Simoni Y; Boitard C; Lehuen A
Eur J Immunol; 2014 May; 44(5):1454-66. PubMed ID: 24481989
[TBL] [Abstract][Full Text] [Related]
18. TLR9 blockade inhibits activation of diabetogenic CD8+ T cells and delays autoimmune diabetes.
Zhang Y; Lee AS; Shameli A; Geng X; Finegood D; Santamaria P; Dutz JP
J Immunol; 2010 May; 184(10):5645-53. PubMed ID: 20393135
[TBL] [Abstract][Full Text] [Related]
19. High density insulin receptor-positive T lymphocytes from nonobese diabetic mice transfer insulitis and diabetes.
McInerney MF; Flynn JC; Goldblatt PJ; Najjar SM; Sherwin RS; Janeway CA
J Immunol; 1996 Oct; 157(8):3716-26. PubMed ID: 8871675
[TBL] [Abstract][Full Text] [Related]
20. CCR7 mediates the migration of Foxp3+ regulatory T cells to the paracortical areas of peripheral lymph nodes through high endothelial venules.
Ueha S; Yoneyama H; Hontsu S; Kurachi M; Kitabatake M; Abe J; Yoshie O; Shibayama S; Sugiyama T; Matsushima K
J Leukoc Biol; 2007 Nov; 82(5):1230-8. PubMed ID: 17698914
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
